RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats

Biochemistry, Genetics and Molecular Biology

• Phosphotransferase 100%
• Kinase 100%
• Cyclic Adenosine Monophosphate 100%
• Stroke Prone Spontaneously Hypertensive Rat 100%
• Wistar Kyoto Rat 100%
• Phosphatase 100%
• Myosin 100%
• Expression Level 100%
• CGMP-dependent Protein Kinase 66%
• Angiotensin 66%
• phosphorylation 66%
• Downregulation 33%
• Rat Model 33%
• Y-27632 33%
• Guanylate Cyclase 33%
• Phosphoprotein 33%
• Protein Kinases 33%
• Receptor Antagonist 33%
• Guanine Nucleotide Exchange Factor 33%
• Cyclic Guanosine Monophosphate 33%
• Myosin Light-Chain Kinase 33%
• Cyclic Nucleotide 33%
• Molecular Mechanism 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Stroke Prone Spontaneously Hypertensive Rat 100%
• Wistar Kyoto Rat 100%
• Myosin 100%
• Phosphatase 100%
• Rho Kinase 66%
• Cyclic GMP Dependent Protein Kinase 1 66%
• Rat Model 33%
• Rho Kinase Inhibitor 33%
• Cyclic AMP 33%
• Leukemia 33%
• Angiotensin II 33%
• Phosphoprotein 33%
• Protein Kinases 33%
• Guanylate Cyclase 33%
• Cyclic GMP 33%
• Angiotensin 1 Receptor Antagonist 33%
• Guanine Nucleotide Exchange Factor 33%
• Myosin Light Chain Kinase 33%
• Valsartan 33%
• Cyclic Nucleotide 33%
• Rho Guanine Nucleotide Dissociation Inhibitor 33%
• Hypertension 33%

Keyphrases

• SHRSP 100%
• Vascular Smooth muscle Cells 100%
• RhoA Activation 100%
• RhoA 55%
• Expression Level 33%
• Wistar Rats 33%
• Myosin Phosphatase Target Subunit 1 22%
• Rho Kinase 22%
• Cyclic GMP 22%
• Phosphorylation State 22%
• Hypertension 11%
• Cyclic Adenosine Monophosphate (cAMP) 11%
• Molecular Mechanism 11%
• Rat Model 11%
• Guanine nucleotide Exchange Factor 11%
• Active Form 11%
• Protein Kinase 11%
• Y-27632 11%
• Rho Kinase Inhibitor 11%
• Leukemia 11%
• Angiotensin II (Ang II) 11%
• Guanylate Cyclase 11%
• Molecular Switches 11%
• Possible Mechanisms 11%
• Aorta 11%
• Phosphoprotein 11%
• Human Aortic Smooth muscle Cells (HASMCs) 11%
• Valsartan 11%
• CAMP-dependent Protein Kinase 11%
• GDP Dissociation Inhibitor 11%
• Intracellular Content 11%
• Myosin Light Chain Kinase 11%
• Myosin Phosphatase 11%
• Angiotensin II Type 1 Receptor Antagonist 11%
• Cyclic nucleotide Signaling 11%
• CPI-17 11%
• Cyclic GMP-dependent Protein Kinases 11%
• Hypertensive Model 11%
• Autocrine/paracrine Regulation 11%